# Caribou Biosciences (CRBU) — Earnings

CRBU · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/crbu/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.35 |
| EPS estimate | −$0.40 |
| EPS surprise | +13.04% |
| Revenue surprise | +53.28% |
| Revenue | $2.7M |
| Revenue estimate | $1.7M |
| Reported | Aug 12, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1619856/000161985625000061/crbu-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 12, 2025 | −$0.40 | −$0.35 | 13.04% | $1.7M | $2.7M |
| Q1 2025 | May 8, 2025 | −$0.43 | −$0.43 | 0.92% | $1.8M | $2.4M |
| Q4 2024 | Mar 10, 2025 | −$0.42 | −$0.39 | 6.59% | $2.1M | $2.1M |
| Q3 2024 | Nov 6, 2024 | −$0.45 | −$0.38 | 15.48% | $3.1M | $2.0M |
| Q2 2024 | Aug 6, 2024 | −$0.46 | −$0.42 | 8.30% | $3.0M | $3.5M |
| Q1 2024 | May 7, 2024 | −$0.41 | −$0.46 | -11.95% | $2.4M | $2.4M |
| Q4 2023 | Mar 11, 2024 | −$0.37 | −$0.39 | -6.12% | $4.0M | $3.6M |
| Q3 2023 | Nov 7, 2023 | −$0.42 | −$0.12 | 71.17% | $3.3M | $23.7M |
| Q2 2023 | Aug 8, 2023 | −$0.49 | −$0.48 | 3.01% | $3.1M | $3.8M |
| Q1 2023 | May 9, 2023 | −$0.48 | −$0.46 | 4.29% | $2.8M | $3.5M |
| Q4 2022 | Mar 9, 2023 | −$0.46 | −$0.44 | 4.66% | $3.1M | $3.7M |
| Q3 2022 | Nov 8, 2022 | −$0.48 | −$0.44 | 8.90% | $3.7M | $3.3M |
| Q2 2022 | Aug 9, 2022 | −$0.36 | −$0.44 | -21.15% | $2.9M | $4.2M |
| Q1 2022 | May 9, 2022 | −$0.35 | −$0.32 | 7.38% | $3.2M | $2.7M |
| Q4 2021 | Mar 21, 2022 | −$0.36 | −$0.31 | 13.34% | $4.2M | $2.6M |
| Q3 2021 | Nov 9, 2021 | −$0.12 | −$0.46 | -280.48% | $16.5M | $4.0M |
| Q2 2021 | Sep 2, 2021 | $0.42 | −$1.39 | -429.46% | $16.5M | $1.5M |

## Frequently Asked Questions

### When did Caribou Biosciences (CRBU) last report earnings?

Caribou Biosciences last reported on Aug 12, 2025, covering fiscal Q2 2025.

### Did CRBU beat earnings estimates?

Yes. Caribou Biosciences reported EPS of −$0.35 for Q2 2025 against a −$0.40 estimate — a 13.04% beat.

### How much revenue did CRBU report last quarter?

Caribou Biosciences reported $2.7M in revenue for Q2 2025, against a consensus estimate of $1.7M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).